Blog

By Susan Brinkmann, OCDS Staff Writer In what may be the first “fruits” of President Obama’s decision to allow taxpayer funding of experimentation on embryos, General Electric (GE) has announced a new liaison with Geron Corporation to begin using embryonic stem cells for the purpose of testing toxic effects of drug treatments.

Read the rest